Crossing borders in Alzheimer's disease: A T cell's perspective

Area of Science:

• Neuroimmunology
• Central Nervous System (CNS) Immunity
• Neurodegenerative Diseases

Background:

• Alzheimer's disease (AD) is a leading cause of dementia with no cure.
• Emerging research highlights the role of the immune system, specifically T cells, in AD pathogenesis.
• Understanding the interplay between systemic immunity and CNS homeostasis is crucial for AD research.

Purpose of the Study:

• To provide a comprehensive overview of T cell contributions to Alzheimer's disease pathology.
• To examine the role of brain barrier changes in T cell involvement in AD.
• To review therapeutic strategies targeting T cells for AD treatment.

Main Methods:

• Literature review of immunological interfaces in the CNS and AD.
• Analysis of studies investigating CD8+ T cell infiltration across brain barriers.
• Synthesis of research on T cell-targeted therapies for AD.

Main Results:

• Subsets of circulating CD8+ T cells infiltrate the brain and correlate with AD pathology.
• Changes at the brain barriers facilitate T cell entry and influence AD progression.
• Systemic immune alterations in AD impact CNS homeostasis.

Conclusions:

• T cell-mediated immunity plays a significant role in Alzheimer's disease pathogenesis.
• Therapeutic strategies targeting T cells offer potential for combating AD and cognitive decline.
• Immune changes in AD extend beyond the CNS, affecting overall brain health.